BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 28472547)

  • 1. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
    Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
    Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Local Treatment on Overall Survival in Patients with Metastatic Prostate Cancer on Diagnosis: A National Cancer Data Base Analysis.
    Löppenberg B; Dalela D; Karabon P; Sood A; Sammon JD; Meyer CP; Sun M; Noldus J; Peabody JO; Trinh QD; Menon M; Abdollah F
    Eur Urol; 2017 Jul; 72(1):14-19. PubMed ID: 27174537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?
    Muralidhar V; Rose BS; Chen YW; Nezolosky MD; Nguyen PL
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):313-317. PubMed ID: 27496390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1).
    Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E
    BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance.
    Lin CC; Bruinooge SS; Kirkwood MK; Olsen C; Jemal A; Bajorin D; Giordano SH; Goldstein M; Guadagnolo BA; Kosty M; Hopkins S; Yu JB; Arnone A; Hanley A; Stevens S; Hershman DL
    J Clin Oncol; 2015 Oct; 33(28):3177-85. PubMed ID: 26304878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes.
    Xu Z; Becerra AZ; Justiniano CF; Boodry CI; Aquina CT; Swanger AA; Temple LK; Fleming FJ
    Dis Colon Rectum; 2017 Dec; 60(12):1250-1259. PubMed ID: 29112560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.
    Speicher PJ; Englum BR; Ganapathi AM; Wang X; Hartwig MG; D'Amico TA; Berry MF
    Ann Surg; 2017 Apr; 265(4):743-749. PubMed ID: 28266965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.
    Ladjevardi S; Sandblom G; Berglund A; Varenhorst E
    Eur Urol; 2010 Apr; 57(4):631-8. PubMed ID: 19299069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer.
    Butler SS; Mahal BA; Lamba N; Mossanen M; Martin NE; Mouw KW; Nguyen PL; Muralidhar V
    Cancer; 2019 Sep; 125(18):3164-3171. PubMed ID: 31150125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients.
    Mauermann J; Fradet V; Lacombe L; Dujardin T; Tiguert R; Tetu B; Fradet Y
    Eur Urol; 2013 Jul; 64(1):19-25. PubMed ID: 22901983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival.
    Graboyes EM; Ellis MA; Li H; Kaczmar JM; Sharma AK; Lentsch EJ; Day TA; Hughes Halbert C
    Cancer; 2018 Aug; 124(15):3181-3191. PubMed ID: 29932220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association between Mortality and Distance to Treatment Facility in Patients with Muscle Invasive Bladder Cancer.
    Ryan S; Serrell EC; Karabon P; Mills G; Hansen M; Hayn M; Menon M; Trinh QD; Abdollah F; Sammon JD
    J Urol; 2018 Feb; 199(2):424-429. PubMed ID: 29030318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Travel distance, hospital volume and their association with ovarian cancer short- and long-term outcomes.
    Knisely A; Huang Y; Melamed A; Tergas AI; St Clair CM; Hou JY; Khoury-Collado F; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2020 Aug; 158(2):415-423. PubMed ID: 32456990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receipt of definitive therapy in elderly patients with unfavorable-risk prostate cancer.
    Yang DD; Mahal BA; Muralidhar V; Boldbaatar N; Labe SA; Nezolosky MD; Vastola ME; Beard CJ; Martin NE; Mouw KW; Orio PF; King MT; Nguyen PL
    Cancer; 2017 Dec; 123(24):4832-4840. PubMed ID: 28832984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival associated with treatment vs observation of localized prostate cancer in elderly men.
    Wong YN; Mitra N; Hudes G; Localio R; Schwartz JS; Wan F; Montagnet C; Armstrong K
    JAMA; 2006 Dec; 296(22):2683-93. PubMed ID: 17164454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.